Activin signaling is an essential component of the TGF-? induced pro-metastatic phenotype in colorectal cancer.
Ontology highlight
ABSTRACT: Advanced colorectal cancer (CRC) remains a critical health care challenge worldwide. Various TGF-? superfamily members are important in colorectal cancer metastasis, but their signaling effects and predictive value have only been assessed in isolation. Here, we examine cross-regulation and combined functions of the two most prominent TGF-? superfamily members activin and TGF-? in advanced colorectal cancer. In two clinical cohorts we observed by immune-based assay that combined serum and tissue activin and TGF-? ligand levels predicts outcome in CRC patients and is superior to single ligand assessment. While TGF-? growth suppression is independent of activin, TGF-? treatment leads to increased activin secretion in colon cancer cells and TGF-? induced cellular migration is dependent on activin, indicating pathway cross-regulation and functional interaction in vitro. mRNA expression of activin and TGF-? pathway members were queried in silico using the TCGA data set. Coordinated ligand and receptor expression is common in solid tumors for activin and TGF-? pathway members. In conclusion, activin and TGF-? are strongly connected signaling pathways that are important in advanced CRC. Assessing activin and TGF-? signaling as a unit yields important insights applicable to future diagnostic and therapeutic interventions.
SUBMITTER: Staudacher JJ
PROVIDER: S-EPMC5514149 | biostudies-literature | 2017 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA